Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma-Reference-Cited by-同舟云学术

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma

Published:2018-10 Issue:10 Volume:29 Page:2143
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Krug A.K.,Enderle D.,Karlovich C.,Priewasser T.,Bentink S.,Spiel A.,Brinkmann K.,Emenegger J.,Grimm D.G.,Castellanos-Rizaldos E.,Goldman J.W.,Sequist L.V.,Soria J -C,Camidge D.R.,Gadgeel S.M.,Wakelee H.A.,Raponi M.,Noerholm M.,Skog J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/29/10/2143/26468590/mdy261.pdf

Reference2 articles.

1. Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma;Krug;Ann Oncol,2018

2. Combining plasma-based biosources to predict treatment response in NSCLC patients;Bracht;Ann Oncol,2018

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of new techniques and clinical applications of liquid biopsy in lung cancer management;Science Bulletin;2024-05

2. Engineered exosomes in emerging cell-free therapy;Frontiers in Oncology;2024-03-26

3. Nanoplasmonic Detection of EGFR Mutations Based on Extracellular Vesicle-Derived EGFR–Drug Interaction;ACS Applied Materials & Interfaces;2024-02-09

4. Exosome as non-invasive prognostic and diagnostic biomarker and nanovesicle for targeted therapy of non-small cell lung carcinoma;Chemical Engineering Journal;2024-01

5. Prospects and Limitations of Clinical Application of Extracellular Vesicles;Biomedical Applications of Extracellular Vesicles;2023-12-08